John P. Hamill, SrVP/CFO/Prin Fin & Acct Ofcr: Aprea Therapeutics APRE Buy · Filed 02/02

Trade details

Type: Insider buy
Amount: $5,073
Shares · price: 5,700 sh · $0.89 a share
Held after: 33,433 sh
Stock: Aprea Therapeutics APRE
Person: John P. HamillSrVP/CFO/Prin Fin & Acct Ofcr
Trade date: 26/01/30
Filed: 26/02/02
Days to filing: 3 days

First buy since 2023

Insiders buying this week: 2 insiders
Holding change: +20.6%

Aprea Therapeutics trades, last 26 weeks

What else happened in Aprea Therapeutics around then

Filed or reported within 30 days of the trade day · 25/12/31~03/01

John P. Hamill's recent trades

John P. HamillSrVP/CFO/Prin Fin & Acct Ofcr
BuyAprea Therapeutics
Buy
Aprea Therapeutics
APRE
$5,850
5,000 sh
$5,850
Filed 25/12/11
Traded 25/12/10
John P. HamillSrVP/CFO/Prin Fin & Acct Ofcr
BuyAprea Therapeutics
Buy
Aprea Therapeutics
APRE
$123
50 sh
$123
Filed 24/10/16
Traded 24/10/11
John P. HamillSrVP/CFO/Prin Fin & Acct Ofcr
BuyAprea Therapeutics
Buy
Aprea Therapeutics
APRE
$1,175
450 sh
$1,175
Filed 24/10/15
Traded 24/10/10
John P. HamillSrVP/CFO/Prin Fin & Acct Ofcr
BuyAprea Therapeutics
Buy
Aprea Therapeutics
APRE
$7,363
1,010 sh
$7,363
Filed 24/03/14
Traded 24/03/13